Trials / Completed
CompletedNCT02466321
Anatomical Shoulder™ Inverse/Reverse Study
Anatomical Shoulder™ Inverse/Reverse Post-Market Surveillance Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Zimmer, GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain outcomes data on the Anatomical Shoulder™ Inverse/Reverse System by analysis of standard scoring systems and radiographs. Outcome data will be collected using the following standard scoring systems of which summary statistics will be provided: • Constant and Murley Score to evaluate clinical parameters such as range of motion, power, level of pain and functional ability.
Detailed description
This is a multi-centre, non-comparative, prospective post-market surveillance study involving orthopaedic surgeons skilled in shoulder replacement surgery. Each case enrolled will receive an Anatomical Shoulder™ Inverse/Reverse implant. All system components are CE-marked and commercially available. Patients will be selected according to the subject selection criteria. All patients will undergo pre-operative, intra-operative and post-operative physical examination, radiographic evaluation according to the hospital's routine procedure and collection of quality of life metrics. Follow-up evaluations are to be conducted at either 6 weeks or 6 months (according to the hospital's standard care plan) and thereafter at 1, 2, 5 and 10 years post hospital discharge. There are 5 study centres taking part in this project enrolling in total a maximum of 160 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Inverse/Reverse Shoulder Arthroplasty | Implantation of the Anatomical Shoulder Inverse/Reverse System |
Timeline
- Start date
- 2007-05-16
- Primary completion
- 2022-02-16
- Completion
- 2024-03-11
- First posted
- 2015-06-09
- Last updated
- 2025-06-12
- Results posted
- 2025-06-12
Locations
5 sites across 4 countries: Belgium, Germany, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02466321. Inclusion in this directory is not an endorsement.